Oxidative Stress Response Kinetics after 60 Minutes at Different (1.4 ATA and 2.5 ATA) Hyperbaric Hyperoxia Exposures

Hyperbaric oxygen therapy (HBOT) is a therapeutical approach based on exposure to pure oxygen in an augmented atmospheric pressure. Although it has been used for years, the exact kinetics of the reactive oxygen species (ROS) between different pressures of hyperbaric oxygen exposure are still not clearly evidenced. In this study, the metabolic responses of hyperbaric hyperoxia exposures for 1 h at 1.4 and 2.5 ATA were investigated. Fourteen healthy non-smoking subjects (2 females and 12 males, age: 37.3 ± 12.7 years old (mean ± SD), height: 176.3 ± 9.9 cm, and weight: 75.8 ± 17.7 kg) volunteered for this study. Blood samples were taken before and at 30 min, 2 h, 24 h, and 48 h after a 1 h hyperbaric hyperoxic exposure. The level of oxidation was evaluated by the rate of ROS production, nitric oxide metabolites (NOx), and the levels of isoprostane. Antioxidant reactions were assessed through measuring superoxide dismutase (SOD), catalase (CAT), cysteinylglycine, and glutathione (GSH). The inflammatory response was measured using interleukine-6, neopterin, and creatinine. A short (60 min) period of mild (1.4 ATA) and high (2.5 ATA) hyperbaric hyperoxia leads to a similar significant increase in the production of ROS and antioxidant reactions. Immunomodulation and inflammatory responses, on the contrary, respond proportionally to the hyperbaric oxygen dose. Further research is warranted on the dose and the inter-dose recovery time to optimize the potential therapeutic benefits of this promising intervention.

[1]  R. Braun,et al.  Hyperbaric air mobilizes stem cells in humans; a new perspective on the hormetic dose curve , 2023, Frontiers in Neurology.

[2]  C. Goergen,et al.  Transport of nitrite from large arteries modulates regional blood flow during stress and exercise , 2023, Frontiers in Cardiovascular Medicine.

[3]  A. Vezzoli,et al.  Oxidative Stress Response Kinetics after 60 Minutes at Different Levels (10% or 15%) of Normobaric Hypoxia Exposure , 2023, International journal of molecular sciences.

[4]  P. Louge,et al.  Validation of sham treatment in hyperbaric medicine: a randomised trial. , 2023, Diving and hyperbaric medicine.

[5]  S. Thom,et al.  Elevations of Extracellular Vesicles and Inflammatory Biomarkers in Closed Circuit SCUBA Divers , 2023, International journal of molecular sciences.

[6]  Y. Cha,et al.  Association between number of hyperbaric oxygen therapy sessions and neurocognitive outcomes of acute carbon monoxide poisoning , 2023, Frontiers in Medicine.

[7]  A. Vezzoli,et al.  The “ON-OFF” Switching Response of Reactive Oxygen Species in Acute Normobaric Hypoxia: Preliminary Outcome , 2023, International journal of molecular sciences.

[8]  A. Vezzoli,et al.  Oxidative Stress Response’s Kinetics after 60 Minutes at Different (30% or 100%) Normobaric Hyperoxia Exposures , 2022, International journal of molecular sciences.

[9]  F. Taccone,et al.  The Normobaric Oxygen Paradox—Hyperoxic Hypoxic Paradox: A Novel Expedient Strategy in Hematopoiesis Clinical Issues , 2022, International journal of molecular sciences.

[10]  J. Maroon The effect of hyperbaric oxygen therapy on cognition, performance, proteomics, and telomere length—The difference between zero and one: A case report , 2022, Frontiers in Neurology.

[11]  S. Thom,et al.  Varying Oxygen Partial Pressure Elicits Blood-Borne Microparticles Expressing Different Cell-Specific Proteins—Toward a Targeted Use of Oxygen? , 2022, International journal of molecular sciences.

[12]  P. Germonpré,et al.  Effects of Acute Hypobaric Hypoxia Exposure on Cardiovascular Function in Unacclimatized Healthy Subjects: A “Rapid Ascent” Hypobaric Chamber Study , 2022, International journal of environmental research and public health.

[13]  P. Harch Systematic Review and Dosage Analysis: Hyperbaric Oxygen Therapy Efficacy in Mild Traumatic Brain Injury Persistent Postconcussion Syndrome , 2022, Frontiers in Neurology.

[14]  Wen Gao,et al.  Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity , 2022, Frontiers in Cell and Developmental Biology.

[15]  G. Millet,et al.  Adaptive responses to hypoxia and/or hyperoxia in humans. , 2022, Antioxidants & redox signaling.

[16]  M. Kox,et al.  The Effect of Hyperbaric Oxygen Therapy on Markers of Oxidative Stress and the Immune Response in Healthy Volunteers , 2022, Frontiers in Physiology.

[17]  U. Ashery,et al.  Hyperbaric Oxygen Treatment: Effects on Mitochondrial Function and Oxidative Stress , 2021, Biomolecules.

[18]  Jiang Zheng,et al.  Imbalanced GSH/ROS and sequential cell death , 2021, Journal of biochemical and molecular toxicology.

[19]  Costantino Balestra,et al.  Oxygen: A Stimulus, Not “Only” a Drug , 2021, Medicina.

[20]  U. Ashery,et al.  Hyperbaric Oxygen Treatment—From Mechanisms to Cognitive Improvement , 2021, Biomolecules.

[21]  A. Paoli,et al.  Oxidative Stress and Inflammation, MicroRNA, and Hemoglobin Variations after Administration of Oxygen at Different Pressures and Concentrations: A Randomized Trial , 2021, International journal of environmental research and public health.

[22]  Costantino Balestra,et al.  Hypoxic and Hyperoxic Breathing as a Complement to Low-Intensity Physical Exercise Programs: A Proof-of-Principle Study , 2021, International journal of molecular sciences.

[23]  S. Mrakic-Sposta,et al.  Comment on Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414 , 2021, Antioxidants.

[24]  T. Bohn,et al.  Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? , 2021, Antioxidants.

[25]  A. Ajayi,et al.  The impact of reactive oxygen species in the development of cardiometabolic disorders: a review , 2021, Lipids in health and disease.

[26]  H. Dainer,et al.  Alternative Uses of Hyperbaric Oxygen Therapy in Military Medicine: Current Positions and Future Directions. , 2021, Military medicine.

[27]  Costantino Balestra,et al.  Increasing Oxygen Partial Pressures Induce a Distinct Transcriptional Response in Human PBMC: A Pilot Study on the “Normobaric Oxygen Paradox” , 2021, International journal of molecular sciences.

[28]  J. Aran,et al.  Reactive Oxygen Species: Drivers of Physiological and Pathological Processes , 2020, Journal of inflammation research.

[29]  S. Mrakic-Sposta,et al.  Change in Oxidative Stress Biomarkers During 30 Days in Saturation Dive: A Pilot Study , 2020, International journal of environmental research and public health.

[30]  Costantino Balestra,et al.  Hyperoxia Alters Ultrastructure and Induces Apoptosis in Leukemia Cell Lines , 2020, Biomolecules.

[31]  S. Mrakic-Sposta,et al.  Oxidative stress assessment in breath-hold diving , 2019, European Journal of Applied Physiology.

[32]  S. Mrakic-Sposta,et al.  Oxidative stress as a biomarker for monitoring treated celiac disease , 2018, Clinical and Translational Gastroenterology.

[33]  Costantino Balestra,et al.  Spirometry and oxidative stress after rebreather diving in warm water. , 2018, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

[34]  P. Szcześniak,et al.  Neopterin as a marker of cellular immunological response. , 2017, Postepy higieny i medycyny doswiadczalnej.

[35]  P. Zhao,et al.  The effects of hyperbaric oxygen therapy on neuropathic pain via mitophagy in microglia. , 2017 .

[36]  S. Mrakic-Sposta,et al.  Oxidative Stress Assessment in Response to Ultraendurance Exercise: Thiols Redox Status and ROS Production according to Duration of a Competitive Race , 2016, Oxidative medicine and cellular longevity.

[37]  L. Barbeito,et al.  Neopterin as a potential cytoprotective brain molecule. , 2015, Journal of psychiatric research.

[38]  Simona Mrakic-Sposta,et al.  A Quantitative Method to Monitor Reactive Oxygen Species Production by Electron Paramagnetic Resonance in Physiological and Pathological Conditions , 2014, Oxidative medicine and cellular longevity.

[39]  C. Franceschi,et al.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[40]  L. Pratali,et al.  Determination of different forms of aminothiols in red blood cells without washing erythrocytes. , 2014, Biomedical chromatography : BMC.

[41]  M. Metra,et al.  Task force on: ‘Early markers of atherosclerosis influence of age and sex’ , 2013, Journal of cardiovascular medicine.

[42]  Costantino Balestra,et al.  Pulsed high oxygen induces a hypoxic-like response in human umbilical endothelial cells and in humans. , 2012, Journal of applied physiology.

[43]  S. Mrakic-Sposta,et al.  Assessment of a Standardized ROS Production Profile in Humans by Electron Paramagnetic Resonance , 2012, Oxidative medicine and cellular longevity.

[44]  Volker Ullrich,et al.  Peroxynitrite as regulator of vascular prostanoid synthesis. , 2009, Archives of biochemistry and biophysics.

[45]  A. Sureda,et al.  Intense physical activity enhances neutrophil antioxidant enzyme gene expression. Immunocytochemistry evidence for catalase secretion , 2007, Free radical research.

[46]  A. Aydın,et al.  The effects of hyperbaric oxygen treatment on oxidative stress and SCE frequencies in humans. , 2005, Clinical biochemistry.

[47]  S. Benedetti,et al.  Oxidative stress and antioxidant status in patients undergoing prolonged exposure to hyperbaric oxygen. , 2004, Clinical biochemistry.

[48]  D. Gutsaeva,et al.  Hyperoxic Vasoconstriction in the Brain Is Mediated by Inactivation of Nitric Oxide by Superoxide Anions , 2003, Neuroscience and Behavioral Physiology.

[49]  Wolzt,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2003, The Journal of the American College of Dentists.

[50]  C. Franceschi,et al.  Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .

[51]  R. Arnold,et al.  Changes in the localization of catalase during differentiation of neutrophilic granulocytes. , 1994, Blood.

[52]  M. Murthy,et al.  The refined structure of beef liver catalase at 2·5 Å resolution , 1986 .

[53]  D. Fuchs,et al.  Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma , 1984, The Journal of experimental medicine.

[54]  D. Fuchs,et al.  Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants. , 1983, Journal of immunology.

[55]  M. Rossmann,et al.  Crystalline bovine liver catalase. , 1976, Journal of molecular biology.

[56]  G. Perdrizet Principles and practice of hyperbaric medicine: a medical practitioner's primer, part I. , 2014, Connecticut medicine.